The use of topical calcineurin inhibitors in dermatology: Safety concerns : Report of the American Academy of Dermatology Association Task Force - 09/08/11
Doi : 10.1016/j.jaad.2006.01.054
Timothy G. Berger, MD a, ⁎ 
, Madeleine Duvic, MD b, Abby S. Van Voorhees, MD c, Ilona J. Frieden, MD a
, Madeleine Duvic, MD b, Abby S. Van Voorhees, MD c, Ilona J. Frieden, MD a a From the Department of Dermatology, University of California
b University of Texas and M. D. Anderson Cancer Center, Houston
c University of Pennsylvania, Philadelphia
Reprint requests: Dr Timothy Berger, c/o Vera LeBrun, 1350 I St NW, Suite 870, Washington, DC 20005.San Francisco, California; Houston, Texas; and Philadelphia, Pennsylvania
Abbreviations used : AD, AE, CTCL, FDA, TCI
Plan
| Authors’ Note: On January 19, 2006, the Food and Drug Administration approved the labeling change to a boxed warning for topical calcineurin inhibitors. This article was submitted prior to that announcement. Readers may find the boxed warning in the Addendum to this article. Additional information and resources are available at tci_information.htm. |
|
| Funding sources: None. Disclosure: Dr Berger is a member of the Speakers Bureau for 3M, Novartis Pharmaceuticals, Dermik Laboratories, and Gilead Sciences and a consultant for Gilead and Doak Dematologics. Dr Frieden is a member of the Novartis Speakers Bureau and Advisory Board. Dr Van Voorhees is participating in a clinical trial sponsored by Astellas Pharmaceuticals and has served as an Advisory Board member for Connetics. Dr Duvic has no conflicts of interest to disclose. |
© 2006
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 54 - N° 5
P. 818-823 - mai 2006 Retour au numéro
Article précédent
- Expression of the heat shock protein-27 in the adult human scalp skin and hair follicle: Hair cycle–dependent changes
- Mohamed A. Adly, Hanan A. Assaf, Mahmoud R. Hussein
- The diagnosis and treatment of iron deficiency and its potential relationship to hair loss
- Leonid Benjamin Trost, Wilma Fowler Bergfeld, Ellen Calogeras
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?